[Frequency of recurrence after Verteporfin photodynamic therapy in AMD].
INTRODUCTION: Photodynamic treatment (PDT) with verteporfin is used to treat choroidal subfoveal neovascularization in age-related macular degeneration (AMD). However, the impact of recurrence after PDT on functional results has not been assessed, although it was previously shown to be higher than 50% after thermal laser treatment for juxtafoveal lesions, and visual prognosis was dramatically worsened by recurrence of choroidal neovascularization. METHOD: Sixty-nine consecutive patients treated with PDT for CNV in AMD were followed every 3 months for up to 3 years. RESULTS: The observed recurrence rate was 17.4%. Recurrence was not associated with a decrease in visual acuity The average number of treatments was 3.0, increasing to 4.9 in case of recurrence. CONCLUSION: The recurrence rate is significantly lower after PDT than after thermal laser. It does not have a negative impact on functional outcome.